Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Bacterial vaginosis primary prevention

Introduction

Overview

Overview

Basic effective measures for the primary prevention of bacterial vaginosis include practicing abstinent, limit the number of sex partner, avoid douching and use of condoms and estrogen-containing contraceptives.[1][2][3]

Primary Prevention

Primary Prevention

Most cases of bacterial vaginosis occur in sexually active women between the ages of 15 and 44, especially after contact with a new partner. Condoms may provide some protection. Although BV appears to be associated with sexual activity, there is no clear evidence of sexual transmission.[4] Basic effective measures for the primary prevention of bacterial vaginosis infection include:[1][2][3]

References

References

  1. ↑ 1.0 1.1 Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, McGregor J; et al. (2002). “Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina”. Obstet Gynecol. 100 (4): 765. PMID 12383547.
  2. ↑ 2.0 2.1 Bradshaw CS, Walker SM, Vodstrcil LA, Bilardi JE, Law M, Hocking JS; et al. (2014). “The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study”. J Infect Dis. 209 (10): 1562–72. doi:10.1093/infdis/jit664. PMID 24285846.
  3. ↑ 3.0 3.1 Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM; et al. (2013). “Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use”. Clin Infect Dis. 56 (6): 777–86. doi:10.1093/cid/cis1030. PMID 23243173.
  4. ↑ Bradshaw CS, Morton AN, Hocking J; et al. (2006). “High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence”. J Infect Dis. 193 (11): 1478&ndash, 86.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]